FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2897617358> ?p ?o ?g. }

• W2897617358 abstract "The Insulin-like growth factor (IGF) pathway plays a role in tumour development and progression. In vivo, IGF1 activity is regulated by the IGF binding proteins (IGFBPs). IGFBP4 inhibits the activity of IGF1 but proteolytic cleavage by pregnancy-associated plasma protein-A (PAPP-A) releases active IGF1. A modified IGFBP4, dBP4, which was resistant to PAPP-A cleavage but retained IGF1 binding capacity, was engineered, expressed in Human Embryonic Kidney (HEK) 293 cells and purified. This study examined the effects of dBP4 on IGF1-induced cell migration, invasion and angiogenesis in vitro. The effect of intra-tumour injections of dBP4 on tumour angiogenesis and metastasis was examined using the 4T1.2luc orthotopic model of breast cancer.PAPP-A resistance and IGF binding capacity of dBP4 were characterized by Western blot and surface plasmon resonance, respectively. 4T1.2luc are mouse mammary adenocarcinoma cells transfected with luciferase to allow in vivo imaging. The effect of dBP4 on IGF1-induced Akt activation in 4T1.2luc cells was assessed by Western blot. Cell migration and invasion assays were performed using 4T1.2luc cells. Angiokit™ assays and Matrigel® implants were used to assess the effects of dBP4 on angiogenesis in vitro and in vivo, respectively. An orthotopic breast cancer model - 4T1.2luc cells implanted in the mammary fat pad of BALB/c mice - was used to assess the effect of intra tumour injection of purified dBP4 on tumour angiogenesis and metastasis. Tumour growth and lung metastasis were examined by in vivo imaging and tumour angiogenesis was evaluated by CD31 immunohistochemistry.Our engineered, PAPP-A resistant IGFBP4 (dBP4) retained IGF1 binding capacity and inhibited IGF1 activation of Akt as well as IGF1-induced migration and invasion by 4T1.2 mammary adenocarcinoma cells. dBP4 inhibited IGF1-induced angiogenesis in vitro and in Matrigel implants in vivo. Direct intra-tumour injection of soluble dBP4 reduced angiogenesis in 4T1.2 luc mammary tumours tumour and reduced lung metastasis.A PAPP-A resistant IGFBP4, dBP4, inhibits angiogenesis and metastasis in 4T1.2 mammary fat pad tumours. This study highlights the therapeutic potential of dBP4 as an approach to block the tumour-promoting actions of IGF1." @default.
• W2897617358 created "2018-10-26" @default.
• W2897617358 creator A5005355595 @default.
• W2897617358 creator A5005409275 @default.
• W2897617358 creator A5006001398 @default.
• W2897617358 creator A5041160849 @default.
• W2897617358 creator A5065316127 @default.
• W2897617358 creator A5066488338 @default.
• W2897617358 creator A5070304067 @default.
• W2897617358 creator A5085876363 @default.
• W2897617358 creator A5087851676 @default.
• W2897617358 date "2018-10-22" @default.
• W2897617358 modified "2023-09-26" @default.
• W2897617358 title "Recombinant PAPP-A resistant insulin-like growth factor binding protein 4 (dBP4) inhibits angiogenesis and metastasis in a murine model of breast cancer" @default.
• W2897617358 cites W1484222701 @default.
• W2897617358 cites W1697889386 @default.
• W2897617358 cites W1863804530 @default.
• W2897617358 cites W1939489297 @default.
• W2897617358 cites W1967818644 @default.
• W2897617358 cites W1968822373 @default.
• W2897617358 cites W1970285990 @default.
• W2897617358 cites W1976299678 @default.
• W2897617358 cites W1984548551 @default.
• W2897617358 cites W1996029988 @default.
• W2897617358 cites W2004040441 @default.
• W2897617358 cites W2006345660 @default.
• W2897617358 cites W2006819054 @default.
• W2897617358 cites W2011834744 @default.
• W2897617358 cites W2014418366 @default.
• W2897617358 cites W2023162617 @default.
• W2897617358 cites W2036997531 @default.
• W2897617358 cites W2043484628 @default.
• W2897617358 cites W2044837043 @default.
• W2897617358 cites W2054891257 @default.
• W2897617358 cites W2059017984 @default.
• W2897617358 cites W2073786886 @default.
• W2897617358 cites W2084632805 @default.
• W2897617358 cites W2088874555 @default.
• W2897617358 cites W2089171551 @default.
• W2897617358 cites W2090361195 @default.
• W2897617358 cites W2090965524 @default.
• W2897617358 cites W2106590135 @default.
• W2897617358 cites W2107585022 @default.
• W2897617358 cites W2115737887 @default.
• W2897617358 cites W2120623956 @default.
• W2897617358 cites W2130788909 @default.
• W2897617358 cites W2132515981 @default.
• W2897617358 cites W2137488285 @default.
• W2897617358 cites W2149370533 @default.
• W2897617358 cites W2160835537 @default.
• W2897617358 cites W2165422073 @default.
• W2897617358 cites W2166042349 @default.
• W2897617358 cites W2328665307 @default.
• W2897617358 cites W2479044294 @default.
• W2897617358 cites W2536679276 @default.
• W2897617358 cites W4245635197 @default.
• W2897617358 doi "https://doi.org/10.1186/s12885-018-4950-0" @default.
• W2897617358 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6196427" @default.
• W2897617358 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30348128" @default.
• W2897617358 hasPublicationYear "2018" @default.
• W2897617358 type Work @default.
• W2897617358 sameAs 2897617358 @default.
• W2897617358 citedByCount "14" @default.
• W2897617358 countsByYear W28976173582019 @default.
• W2897617358 countsByYear W28976173582020 @default.
• W2897617358 countsByYear W28976173582021 @default.
• W2897617358 countsByYear W28976173582022 @default.
• W2897617358 countsByYear W28976173582023 @default.
• W2897617358 crossrefType "journal-article" @default.
• W2897617358 hasAuthorship W2897617358A5005355595 @default.
• W2897617358 hasAuthorship W2897617358A5005409275 @default.
• W2897617358 hasAuthorship W2897617358A5006001398 @default.
• W2897617358 hasAuthorship W2897617358A5041160849 @default.
• W2897617358 hasAuthorship W2897617358A5065316127 @default.
• W2897617358 hasAuthorship W2897617358A5066488338 @default.
• W2897617358 hasAuthorship W2897617358A5070304067 @default.
• W2897617358 hasAuthorship W2897617358A5085876363 @default.
• W2897617358 hasAuthorship W2897617358A5087851676 @default.
• W2897617358 hasBestOaLocation W28976173581 @default.
• W2897617358 hasConcept C121608353 @default.
• W2897617358 hasConcept C126322002 @default.
• W2897617358 hasConcept C150903083 @default.
• W2897617358 hasConcept C170493617 @default.
• W2897617358 hasConcept C207001950 @default.
• W2897617358 hasConcept C2775960820 @default.
• W2897617358 hasConcept C2776996007 @default.
• W2897617358 hasConcept C2778608917 @default.
• W2897617358 hasConcept C2778939058 @default.
• W2897617358 hasConcept C2779013556 @default.
• W2897617358 hasConcept C2780278673 @default.
• W2897617358 hasConcept C2780394083 @default.
• W2897617358 hasConcept C502942594 @default.
• W2897617358 hasConcept C71924100 @default.
• W2897617358 hasConcept C86803240 @default.
• W2897617358 hasConceptScore W2897617358C121608353 @default.
• W2897617358 hasConceptScore W2897617358C126322002 @default.
• W2897617358 hasConceptScore W2897617358C150903083 @default.
• W2897617358 hasConceptScore W2897617358C170493617 @default.
• W2897617358 hasConceptScore W2897617358C207001950 @default.
• W2897617358 hasConceptScore W2897617358C2775960820 @default.

• next